Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Lucas J. Huebner"'
Autor:
Ben L. Sanford, Martin S. Tallman, Richard F. Schlenk, Lucas J. Huebner, Jürgen Krauter, Hartmut Döhner, Maria Teresa Voso, Hubert Serve, Andrew H. Wei, Jorge Sierra, Bruno C. Medeiros, Dietger Niederwieser, Arnold Ganser, Insa Gathmann, Miguel A. Sanz, Joseph Brandwein, Rebecca B. Klisovic, Sergio Amadori, Christian Thiede, Thomas W. Prior, Richard A. Larson, Theo de Witte, Konstanze Döhner, Kristina Laumann, Richard Stone, Clara D. Bloomfield, Frederick R. Appelbaum, Guido Marcucci, Gerhard Ehninger, Ilene Galinsky, Susan Geyer, Sumithra J. Mandrekar
Publikováno v:
Leukemia, 35, 9, pp. 2539-2551
Leukemia, 35, 2539-2551
Leukemia
LEUKEMIA
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
Leukemia, 35, 2539-2551
Leukemia
LEUKEMIA
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
Contains fulltext : 237748.pdf (Publisher’s version ) (Closed access) The prospective randomized, placebo-controlled CALGB 10603/RATIFY trial (Alliance) demonstrated a statistically significant overall survival benefit from the addition of midostau
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32dbedd4a3766d3bcd8c06c784eca412
https://doi.org/10.1038/s41375-021-01179-4
https://doi.org/10.1038/s41375-021-01179-4
Autor:
Lucas J. Huebner, Mei Yin C. Polley, Eric P. Winer, Chau T. Dang, Ann H. Partridge, Lisa A. Carey, Donald A. Berry, Clifford A. Hudis, Charles M. Perou, Jonathan Shepherd, Katherine A. Hoadley, Ian E. Krop, David W. Hillman, N. Lynn Henry, Joel S. Parker, Aranzazu Fernandez-Martinez, Lyndsay Harris, Olwen Hahn, Sara M. Tolaney
Publikováno v:
J Clin Oncol
PURPOSE CALGB 40601 assessed whether dual versus single human epidermal growth factor receptor 2 (HER2) –targeting drugs added to neoadjuvant chemotherapy increased pathologic complete response (pCR). Here, we report relapse-free survival (RFS), ov
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30c4d099194483cb2ebdb2fa67199e87
https://doi.org/10.1200/jco.20.01276
https://doi.org/10.1200/jco.20.01276
Autor:
Sakti, Chakrabarti, Lucas J, Huebner, Heidi D, Finnes, Andrea, Muranyi, June, Clements, Shalini, Singh, Joleen M, Hubbard, Robert R, McWilliams, Kandavel, Shanmugam, Frank A, Sinicrope
Publikováno v:
JCO precision oncology. 3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::919139afc5fb715d9c282db814687567
https://pubmed.ncbi.nlm.nih.gov/35100708
https://pubmed.ncbi.nlm.nih.gov/35100708
Autor:
June Clements, Joleen M. Hubbard, Sakti Chakrabarti, Heidi D. Finnes, Shalini Singh, Robert R. McWilliams, Kandavel Shanmugam, Lucas J. Huebner, Andrea Muranyi, Frank A. Sinicrope
Publikováno v:
JCO Precision Oncology. :1-7
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::612b792a775326656cfcb8d1ff69d4e6
https://doi.org/10.1200/po.19.00055
https://doi.org/10.1200/po.19.00055
Autor:
Jeffrey A. Meyerhardt, Richard M. Goldberg, Eileen M. O'Reilly, Lucas J. Huebner, Charles D. Blanke, Midhun Malla, Heinz-Josef Lenz, Qian Shi, Sorbarikor Piawah, Alan P. Venook
Publikováno v:
Journal of Clinical Oncology. 38:e16076-e16076
e16076 Background: Median overall survival (mOS) of patients (pt) with metastatic colorectal cancer (mCRC) has improved steadily over the past two decades. However, epidemiological data suggest that cancer outcomes for rural compared to urban dwellin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9a375aa8101e840c2a50681d0325d93f
https://doi.org/10.1200/jco.2020.38.15_suppl.e16076
https://doi.org/10.1200/jco.2020.38.15_suppl.e16076
Autor:
Daniel H. Ahn, Lucas J. Huebner, Minetta C. Liu, Martin E. Fernandez-Zapico, Zhaohui Jin, Steven R. Alberts, Hao Xie, Tanios Bekaii-Saab, Lori Durgin, Tara L. Hogenson, William J. Phillips, Nguyen H Tran, Henry C. Pitot, Mitesh J. Borad, Amit Mahipal, Jaclynn Wessling, Qian Shi
Publikováno v:
Journal of Clinical Oncology. 38:TPS594-TPS594
TPS594 Background: Effective treatment options are very limited for patients with advanced refractory biliary tract cancer (BTC). Fluoropyrimidine-based chemotherapy regimen such as 5-fluorouracil and irinotecan are frequently utilized for these pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9218947284c222ce0de9fca531882084
https://doi.org/10.1200/jco.2020.38.4_suppl.tps594
https://doi.org/10.1200/jco.2020.38.4_suppl.tps594
Autor:
Martin S. Tallman, K M Laumann, Richard M. Stone, Hartmut Döhner, Guido Marcucci, Rebecca B. Klisovic, J. Nomdedeu, Hubert Serve, B. Axel, Insa Gathmann, Agnes Gambietz, Bruno C. Medeiros, Francesco Lo-Coco, Christian Thiede, Joseph Brandwein, Nikolaus Jahn, Jurjen Jansen, Frederick R. Appelbaum, Gerhard Ehninger, Thomas W. Prior, Richard A. Larson, A. Ganser, Sumithra J. Mandrekar, Jürgen Krauter, Celine Pallaud, Dan Jones, Richard F. Schlenk, Susan Geyer, Jordi Sierra, T. de Witte, H. Michael, S. Amadori, Konstanze Döhner, Tiziana Ottone, Andrew H. Wei, Clara D. Bloomfield, P. Ekaterina, Dietger Niederwieser, Miguel A. Sanz, Lucas J. Huebner
Publikováno v:
HemaSphere. 3:81-82
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::01dfe08510aae81441cb01c0164411a1
https://doi.org/10.1097/01.hs9.0000559252.96061.3e
https://doi.org/10.1097/01.hs9.0000559252.96061.3e
Autor:
Joleen M. Hubbard, Lucas J. Huebner, June Clements, Shalini Singh, Sakti Chakrabarti, Andrea Muranyi, Robert R. McWilliams, Kandavel Shanmugam, Frank A. Sinicrope, Heidi D. Finnes
Publikováno v:
Journal of Clinical Oncology. 37:3532-3532
3532 Background: Colorectal cancer with dMMR display heterogeneity in the extent of intratumoral T-cell infiltration which may explain their variable responsiveness to PD-1 blockade. We examined the association of intratumoral CD3+ and CD8+ T-cell de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a2edefe6c6a4082150d6e619b66dcf77
https://doi.org/10.1200/jco.2019.37.15_suppl.3532
https://doi.org/10.1200/jco.2019.37.15_suppl.3532
Autor:
Pierre Laurent-Puig, Karine Le Malicot, Gunnar Folprecht, Qian Shi, Lucas J. Huebner, Richard M. Goldberg, Julien Taieb, Frank A. Sinicrope, Josep Tabernero, Steven R. Alberts, Aziz Zaanan, Thomas C. Smyrk, Enrico Mini
Publikováno v:
Journal of Clinical Oncology. 37:3520-3520
3520 Background: Duration of adjuvant FOLFOX or CAPOX for stage III CC is being guided by pt stratification into low (T1-3N1) and high (T4 or N2) risk groups based on the IDEA study. We determined the relative contributions of clinical and molecular
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cca560e791544f9861bc873b529611f9
https://doi.org/10.1200/jco.2019.37.15_suppl.3520
https://doi.org/10.1200/jco.2019.37.15_suppl.3520